Roscosmos, the company INVITRO and 3D Bioprinting Solutions announced the successful completion of the first phase of the experiment "3D-Magnetic Bioprinter", performed on board ISS. For the first time, human cartilage and rodent thyroid tissues were printed in space.
The Russian bioprinter Organ.Avt was delivered to the ISS on December 3, 2018 on a manned spacecraft Soyuz MS-11. Preparation for the project continued for two years. It was important for scientists to analyze how space microgravity affects the efficiency of the process of creating living tissues and organ constructs.
The joint project of INVITRO, 3D Bioprinting Solutions and the Roscosmos State Corporation, with the support of the Skolkovo Foundation, was the first ever orbit experiment initiated by a Russian private company.
In addition to technical and scientific innovations, a whole range of new organizational approaches was applied to the experiment, which will be further translated to other companies working with the public sector in the space technology and innovation segment. According to Andrey Divaev, head of research and development at the Department of Business Systems of Roscosmos State Corporation, partnership with a private company in this format has become a unique experience for the State Corporation, which will help in further projects with commercial companies.
Biological material printed in space, will return to Earth on December 20 at the Union MS-09. In the first half of 2019, 3D Bioprinting Solutions will summarize the results of the space experiment and publish its results. A similar American experiment is scheduled for February 2019.
https://www.roscosmos.ru/25849/